Genmab A/SEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 1844 DKK | 2.257 DKK | 1.337 DKK |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - DKK | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 61.393.589 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Genmab A/S
Mitarbeiter 3.088
Handelsplatz CO
Ticker Symbol GMAB
IPO Datum -
Adresse Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500
Webseite https://www.genmab.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
| 2 | Mr. Anthony Pagano CPA | Executive VP & CFO |
| 3 | Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
| 4 | Mr. Gregory David Emil Mueller | Executive VP, General Counsel & Chief Legal Officer |
| 5 | Mr. Christopher Cozic | Executive VP & Chief People Officer |
| 6 | Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
| 7 | Mr. Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director |
| 8 | Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
| 9 | Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
| 10 | Dr. Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.